April 25, 2016
1 min watch
Save

VIDEO: Limited knowledge about Zika poses challenge in vaccine development

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BALTIMORE — Col. Paul B. Keiser, MD, from the Walter Reed Army Institute of Research, reviews current progress in the development of a Zika virus vaccine. Researchers are now in the process of selecting a strain and producing clinical lots of an inactivated vaccine. A significant challenge, according to Keiser, is our limited knowledge about the virus.

“We are learning more every single day,” he says.

Disclosure: Keiser reports no relevant financial disclosures.